The Kobe combination therapy of losartan plus HCTZ (losartan/HCTZ), effect and safety trial (Kobe-CONNECT) Study was designed to compare the effectiveness and safety of losartan/HCTZ with that of the ...

More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Since ...

Several clinical trials have demonstrated the relative tolerability of losartan. [8,14,18,19,20] The most frequent adverse reaction, as observed in a clinical trial of 2900 patients assessing the ...

Renin–angiotensin system (RAS) blockers have shown clinical outcomes superior to those of the beta (β)-blocker atenolol, despite similar reductions in the peripheral blood pressure (BP), perhaps ...